Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1502.4000 -11.40 (-0.75%)
NSE Jun 27, 2025 15:31 PM
Volume: 1.9M
 

logo
Cipla Ltd.
15 May 2020
1502.40
-0.75%
Sharekhan
Cipla reported weak numbers for Q4FY2020 impacted by the ongoing COVID-19 pandemic, which led to operational disruptions. Revenues were flat at Rs. 4,376 crore. The India and the API business grew in double digits while the North America business reported a decline in revenue. Operating profits, at Rs 633 crore, dropped by 34% y-o-y while OPM contracted by 730 bps y-o-y to 14.5%. OPM reflected an impact of 200 bps on account of the COVID-19 related issues. Adjusted PAT at Rs. 246 crore dropped by 53% y-o-y. The management expects the impact of COVID-19 to be short-lived and has guided for a recovery in the near term. Cipla's domestic...
Cipla Ltd. has an average target of 1699.67 from 9 brokers.
More from Cipla Ltd.
Recommended